BioHarvest Sciences Inc. Common Stock (BHST)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Dr. Zaki Rakib Ph.D.
|
Co-Founder, CEO, Executive Chairman & President | 499.2k | -- | 1959 |
|
Dr. Yoheved Hagay Ph.D.
|
Co-Founder & CTO | 349.57k | -- | 1958 |
|
Ms. Bar Dichter
|
Chief Financial Officer | 181.11k | -- | -- |
|
Dr. Ilana Belzer Ph.D.
|
Chief Operating Officer | 315.2k | -- | 1960 |
|
Mr. David K. Ryan
|
VP of Investor Relations & Secretary | 42.78k | -- | 1967 |
|
Jared Turner
|
Chief Sales Officer | 298k | -- | -- |
|
Dr. Malkit Azachi Ph.D.
|
Vice President of Research & Development | 214.34k | -- | -- |
|
Ms. Michal Abargel Sapir
|
Vice President of Regulatory Affairs | 185.23k | -- | -- |
BioHarvest Sciences Inc. Common Stock
- Sector:
- Consumer Defensive
- Industry: Packaged Foods
- Full Time Employees:
- 89
Description
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules. The company is based in Vancouver, Canada.
Corporate Governance
Upcoming Events
November 12, 2026 at 1:30 PM UTC
BioHarvest Sciences Inc. Common Stock Earnings Date
